Luye Pharma Group Ltd.

Direct answer

Luye Pharma Group Ltd. is publicly traded on HKSE under the ticker 2186.HK.

Luye Pharma Group Ltd. functions as a global investment holding enterprise, focusing on the worldwide development, production, marketing, and sales of pharmaceutical products. The company's diverse portfolio includes several key oncology treatments: Lipusu for ovarian and breast cancers; CMNa, a chemical sensitizer used in cancer radiotherapy; Tiandida, targeting ovarian or non-small cell lung cancer; and Boyounuo,...

Can you invest in Luye Pharma Group Ltd.?

Yes. Luye Pharma Group Ltd. is publicly traded on HKSE under the ticker 2186.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Luye Pharma Group Ltd.

Detailed equity research is provided by MarketSnap.